IO BIOTECH INC IOBTQ
COM · Common Stock · CUSIP 449778109
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.96.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 22 |
| Q4 2022 | 18 |
| Q1 2023 | 18 |
| Q2 2023 | 16 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 4 | 9 |
| Q1 2023 | 4 | 5 |
| Q2 2023 | 6 | 6 |
Biggest buyers
| PFM Health Sciences, LP | Added | +105.1k |
| Aureus Asset Management, LLC | New | +43.7k |
| Summit Trail Advisors, LLC | New | +43.7k |
| MORGAN STANLEY | Added | +25.8k |
| TWO SIGMA SECURITIES, LLC | New | +13.0k |
| RENAISSANCE TECHNOLOGIES LLC | Added | +7.4k |
Biggest sellers
| Point72 Asset Management, L.P. | Sold out | -1.4m |
| Capital World Investors | Sold out | -418.5k |
| Newtyn Management, LLC | Sold out | -49.3k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -19.9k |
| CANNELL CAPITAL LLC | Sold out | -12.6k |
| CITADEL ADVISORS LLC | Reduced | -9.2k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Lundbeckfond Invest A/S
13D · may seek influence
filed 2026-06-02
Stated purposeItem 4 of the Statement is hereby amended and supplemented as follows: On March 31, 2026, the Issuer ceased operations and filed a voluntary petition for relief (the "Petition") under the provisions of Chapter 7 of Title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the District of Delaware. The assets of the Issuer will be liquidated and claims paid in accordance with the priorities specified in the Bankruptcy Code. Concurrently with the Petition, on March 31, 2026, each member of the Issuer's board of directors, including Christian Elling, resigned from the Board of Directors of the Issuer and all of its committees. Full filing |
27.4% |
Fell to 5% or below in the last year: Chernett Jorey (0.0%, 2026-05-20), Point72 Asset Management, L.P. (0.0%, 2026-05-15), HBM Healthcare Investments (Cayman) Ltd. (3.3%, 2026-04-06), Novo Holdings A/S (3.3%, 2026-01-23)
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| NOVO HOLDINGS A/S 0.50% of their portfolio | 3.3m $6.4m | Unchanged |
| Vivo Capital, LLC 0.41% of their portfolio | 3.0m $5.9m | Unchanged |
| Avoro Capital Advisors LLC 0.05% of their portfolio | 2.1m $4.0m | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 1.9m $3.6m | Unchanged |
| SAMSARA BIOCAPITAL, LLC 0.35% of their portfolio | 1.0m $2.0m | Unchanged |
| PFM Health Sciences, LP 0.05% of their portfolio | 612.7k $1.2m | Added +105.1k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 132.2k $259.1k | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 69.1k $135.0k | Added +7.4k |
| MORGAN STANLEY 0.00% of their portfolio | 68.9k $134.8k | Added +25.8k |
| Aureus Asset Management, LLC 0.01% of their portfolio | 43.7k $85.5k | New |
| Summit Trail Advisors, LLC 0.00% of their portfolio | 43.7k $85.5k | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 37.7k $73.9k | Reduced -9.2k |
| TWO SIGMA SECURITIES, LLC 0.00% of their portfolio | 13.0k $25.5k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 12.7k $24.9k | Unchanged |
| Ancora Advisors LLC 0.00% of their portfolio | 908 $1.8k | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |